Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Achillion jumps on hepatitis C study
Marketwatch
Monday, May 21, 2012 - 4:49pm
tags:
Achillion, hepatitis C, ACH-2684
5 Reasons To Buy Navidea Biopharmaceuticals
Seeking Alpha
Monday, May 21, 2012 - 4:37pm
tags:
Navidea Biopharmaceuticals, AstraZeneca
Teva's New CEO: A Positive Catalyst Going Forward
Seeking Alpha
Monday, May 21, 2012 - 4:36pm
tags:
Teva Pharmaceuticals, Pharma CEOs, Novartis, Bristol-Myers Squibb
Erectile Dysfunction: Vivus' Stendra Can't Stop Cialis
Motley Fool
Monday, May 21, 2012 - 4:20pm
tags:
erectile dysfunction, Vivus, Stendra, Cialis, Eli Lilly
Contract sales sector “shrunk” in 2011, PDI CEO says
Outsourcing Pharma
Monday, May 21, 2012 - 12:57pm
tags:
contract sales, PDI, Nancy Lurker
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers
Xconomy
Monday, May 21, 2012 - 12:55pm
tags:
Regeneron, Illumina, Vivus, Seattle Genetics, Cubist Pharmaceuticals, Onyx
Pfizer Rep: I Was Fired For Being Pregnant
Pharmalot
Monday, May 21, 2012 - 12:53pm
tags:
Pfizer, gender discrimination, King Pharmaceuticals, drug reps
Sucampo presents data for AMITIZA for treatment of IBS-C
Yahoo/Fly on the Wall
Monday, May 21, 2012 - 12:52pm
tags:
Sucampo, Amitiza, IBS, IBS-C
Outlooks for Pfizer, Arena and Onyx Following Busy May
TheStreet.com
Monday, May 21, 2012 - 12:28pm
tags:
Pfizer, Arena Pharmaceuticals, Onyx, lorcaserin, JAK3 inhibitors, Merck, Carfilzomib
4 Reasons To Buy Ventrus Biosciences
Seeking Alpha
Monday, May 21, 2012 - 12:23pm
tags:
Ventrus
What You Must Know Before Investing in Prostate Cancer Stocks
Minyanville
Monday, May 21, 2012 - 12:22pm
tags:
prostate cancer, Dendreon, Cougar Biotechnology, JNJ, Medivation, Exelixis
FDA staff sends mixed message on J&J drug Xarelto
Reuters
Monday, May 21, 2012 - 12:20pm
tags:
FDA, JNJ, Xarelto, bloodthinners
Auxilium, GlaxoSmithKline enter co-promotion agreement for Testim
Yahoo/Fly on the Wall
Monday, May 21, 2012 - 12:19pm
tags:
GSK, Testim, Auxilium, testosterone
Bristol-Myers Squibb's Thud Heard Round the World
Motley Fool
Monday, May 21, 2012 - 12:19pm
tags:
Bristol-Myers Squibb, Plavix, bloodthinners, Sanofi, Dr Reddy's, generics, Sun Pharma
BioPharm Systems to Host Webinar on Merging Multiple Drug Safety and Pharmacovigilance Databases Into One Global Oracle Argus Safety System
Health Care Global
Sunday, May 20, 2012 - 12:37pm
tags:
BioPharm Systems
Sucampo Pharmaceuticals, Inc. : Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C)
4-Traders
Sunday, May 20, 2012 - 12:35pm
tags:
Sucampo, Amitiza, irritable bowel syndrome
AstraZeneca looks to revive experimental drugs
Financial Times, UK
Sunday, May 20, 2012 - 12:34pm
tags:
AstraZeneca, R&D
China Biotech Week In Review: J&J Actively Pursuing M&A In China
Seeking Alpha
Sunday, May 20, 2012 - 12:33pm
tags:
JNJ, M&A, China National Biotech Group, Zhejiang Conba Pharma, Ningbo David Medical Device Co, Ventac Partners, Shanxi Zhendong Pharmaceutical Company, Bristol-Myers Squibb, Novozymes Biopharma, Zhejiang Hisun Pharma, ThermoDox
GlaxoSmithKline completes transaction to increase its ownership in Theravance
PharmPro
Sunday, May 20, 2012 - 12:28pm
tags:
GSK, Theravance, M&A
US bioethics centre queried about ties to drug industry
BioEdge
Sunday, May 20, 2012 - 12:26pm
tags:
painkillers, pain management

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.